Molecular processing of tau protein in progressive supranuclear palsy: neuronal and glial degeneration

Manuscript Number: 

20-1139R2

Author(s): 
Patricia Bocanegra-López, Marely Bravo-Muñoz, Benjamín Florán-Garduño, Linda Garcés-Ramírez, Raúl García-Tapia Prandiz, Charles R. Harrington, José Luna-Muñoz, Alejandra Martínez-Maldonado, Sandra Martínez-Robles, José Francisco Montiel-Sosa, Miguel Ángel Ontiveros-Torres, Mar Pacheco-Herrero, George Perry, Andrew Michael Sorsby-Vargas, Ignacio Villanueva-Fierro, Fidel de la Cruz

Disclosures

Patricia Bocanegra-López

  • Nothing to Disclose

Marely Bravo-Muñoz

  • Nothing to Disclose

Fidel de la Cruz

  • Nothing to Disclose

Benjamín Florán-Garduño

  • Nothing to Disclose

Linda Garcés-Ramírez

  • Nothing to Disclose

Raúl García-Tapia Prandiz

  • Nothing to Disclose

Charles R. Harrington

  • Equity:
    I have share options in TauRx Therapeutics Ltd.
    Patents/Royalties
    I am an inventor on patents owned by WisTa Laboratories Ltd, an affiliate of TauRx Therapeutics Ltd,, in the field of tau-related neurodegenerative disorders. I serve as Chief Scientific Officer for TauRx Therapeutics Ltd,

José Luna-Muñoz

  • Nothing to Disclose

Alejandra Martínez-Maldonado

  • Nothing to Disclose

Sandra Martínez-Robles

  • Nothing to Disclose

José Francisco Montiel-Sosa

  • Nothing to Disclose

Miguel Ángel Ontiveros-Torres

  • Nothing to Disclose

Mar Pacheco-Herrero

  • Nothing to Disclose

George Perry

  • Consulting Fees:
    Neurotrope Nervgen Investicure
    Equity:
    Neurotez Neurotrope Investicure

Andrew Michael Sorsby-Vargas

  • Nothing to Disclose

Ignacio Villanueva-Fierro

  • Nothing to Disclose